MARK OLDAKOWSKI - 17 Feb 2026 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
17 Feb 2026
Net transactions value
-$22
Form type
4
Filing time
18 Feb 2026, 16:26:55 UTC
Previous filing
04 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
OLDAKOWSKI MARK CHIEF OPERATING OFFICER C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO /s/ Jonathan V. Dixon, Attorney-in-Fact 18 Feb 2026 0001745566

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Tax liability $22 -20 -2.2% $1.10 895 17 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.